BLOG

NK Cell Therapy Alongside Standard Cancer Treatment in Osaka

Published 2026.10.12 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you are living with cancer, you may be wondering whether an immune cell therapy can be received at the same time as the treatment you already have. This is one of the most common questions international patients ask when they look into NK cell therapy in Osaka. This article explains, in general terms, how the question is usually approached, and what to prepare before you speak with a doctor at Grand Green Osaka Umekita Clinic.

Please note that this article is general information only. It is not medical advice, and it cannot tell you whether any treatment is suitable for you.

The short answer: it depends on your situation and your doctors

NK cell therapy is an immune cell therapy in which your own natural killer (NK) cells are collected from a standard blood draw, activated and expanded outside the body at a specialized facility, and then returned by intravenous infusion. According to the clinic’s treatment information, it is not intended to replace surgery, chemotherapy, or radiation therapy, and the clinic describes it as designed not to interfere with these standard treatments. In other words, it is considered a possible addition rather than an alternative.

Whether it makes sense for you is a medical decision. It depends on your cancer type, your stage, the treatment schedule you are following, your blood test results, and your overall condition. For that reason, the first step is always a consultation, not a decision made from reading a web page.

Why people consider NK cell therapy alongside standard treatment

NK cells are innate immune cells that patrol the body and can recognize and attack abnormal cells, including cancer cells, without waiting for instructions from other immune cells. Researchers describe this process as immune surveillance. Published research also suggests that NK cell activity can decline with age, stress, and the effects of cancer itself, and that treatments such as chemotherapy may influence immune function as well.

The idea behind NK cell therapy is to return a larger number of more active NK cells to the body, with the aim of supporting weakened immune function. It is important to be realistic here. Research on NK cell approaches is still developing, results differ between studies and cancer types, and no one can promise that this therapy will work for a particular person. Standard treatment remains the foundation of cancer care, and it should be decided with your primary oncology team.

Many patients are drawn to the following points, which the clinic describes as features of the therapy:

It uses your own (autologous) cells, so the risk of rejection is considered low.
Treatment involves a blood draw and an IV infusion, usually without hospitalization.
It can be coordinated with the medical institution that provides your standard treatment.
Temporary fever or fatigue may occur, and any other effects should be discussed with your doctor.

How timing and coordination are usually discussed

Because NK cell therapy involves culturing cells over a period of time, planning ahead matters. Timing is something that should be arranged individually, and it should never be changed on your own. If you are in the middle of chemotherapy or radiation, or are preparing for surgery, your oncology team may have views about when an additional therapy is appropriate, and these views should be heard.

At Grand Green Osaka Umekita Clinic, the clinic states that it can coordinate with the medical institution providing your standard treatment. In practice, this usually means that you share your diagnosis, your current treatment plan, and recent test results, so that the doctors can talk about the safest approach. If you are traveling from overseas, it is wise to raise the question of coordination early, before you book flights and accommodation.

You should also never stop or delay a recommended standard treatment in order to start an immune cell therapy. If you are unsure, ask both your home physician and the clinic in Osaka the same question and compare their answers.

What to know about safety, regulation, and costs in Japan

In Japan, NK cell therapy of this kind is provided as a self-pay (non-insured) treatment. It is not covered by public health insurance, so the costs are paid by the patient. Because it is a form of regenerative medicine, it is provided under Japan’s Act on the Safety of Regenerative Medicine, with a treatment plan that has been reviewed by a certified committee and submitted to the Ministry of Health, Labour and Welfare, and with cells processed at a licensed cell processing facility. This framework is meant to support safety management, but it does not remove all risk, and it is not a guarantee of results.

Costs, the number of infusions, the treatment period, possible side effects, and who is eligible are all matters that need to be confirmed with a doctor after an examination. Please check the fees and risk information on the official treatment page before making a decision, and ask for the details in writing if you need them for your own records or for your home doctor.

Preparing for a consultation in Osaka as an international patient

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka, and it provides information pages for international patients in several languages. A little preparation can make the first conversation much more useful. Consider bringing or sending the following:

A summary of your diagnosis, including cancer type and stage, ideally in English.
Your current and planned standard treatments, with dates.
Recent blood test results and imaging reports, if available.
A list of medicines and supplements you take, and any allergies.
Your questions about timing, side effects, costs, and what follow-up would look like if you return home.

It is also reasonable to ask how the clinic will communicate with your home doctors, and what the realistic limits of the therapy are. A good consultation should leave you with a clearer picture, not with pressure to decide quickly.

In summary, NK cell therapy is discussed as a possible option that can be considered alongside standard cancer treatment, but whether it is suitable, and how it should be timed, can only be decided by your doctors after a medical examination. If you would like to learn more, you can read the official NK cell therapy page of Grand Green Osaka Umekita Clinic and arrange a consultation.

Before You Consult

Keep standard careNot a replacement
Coordinate your doctors
Self-pay treatmentConfirm costs and risks
Prepare your records

This figure is a conceptual summary of the article content

Learn more about NK Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to NK Cell Therapy ›